The first-in-class WASP activator EG-011 is active in lymphoma and multiple myeloma cell lines resistant to FDA approved compounds. (October 2022) - Spriano, F.; Arribas, A.J.; Tarantelli, C.; Sartori, G.; Gaudio, E.; Driessen, C.; Bertoni, F.